acetylglucosamine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihara, Y; Kanayama, Y; Matuzawa, Y; Nakao, H; Nishikawa, A; Nishiura, T; Taniguchi, N; Yoshimura, M | 1 |
1 other study(ies) available for acetylglucosamine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
High expression of UDP-N-acetylglucosamine: beta-D mannoside beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in chronic myelogenous leukemia in blast crisis.
Topics: Acetylglucosamine; Blast Crisis; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycosylation; Humans; Immunoblotting; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Leukocyte Common Antigens; Mannose; Molecular Probe Techniques; Multiple Myeloma; N-Acetylglucosaminyltransferases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Processing, Post-Translational; RNA, Messenger; Tumor Cells, Cultured | 1995 |